Basal and angiotensin II-inhibited neuronal delayed-rectifier K+ current are regulated by thioredoxin

American Journal of Physiology - Cell Physiology

Volumn 293, Issue 1, 2007, Pages

  Matsuura, Tomokazu ^a   Harrison, Rachael A ^a   Westwell, Andrew D ^b   Nakamura, Hajime ^c   Martynyuk, Anatoly E ^d   Sumners, Colin ^a,d  

^a UNIVERSITY OF FLORIDA   (United States)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c KYOTO UNIVERSITY HOSPITAL   (Japan)

^d UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Neuronal activity; Patch clamp; Thiol protein oxidoreductase

Indexed keywords

ANGIOTENSIN II; DELAYED RECTIFIER POTASSIUM CHANNEL; MACROPHAGE MIGRATION INHIBITION FACTOR; MUTANT PROTEIN; OXIDOREDUCTASE; OXIDOREDUCTASE INHIBITOR; PMX 464; RECOMBINANT PROTEIN; THIOL PROTEIN OXIDOREDUCTASE; THIOREDOXIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BRAIN NERVE CELL; BRAIN STEM; CELL ACTIVITY; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; HYPOTHALAMUS; NERVE CELL; NEWBORN; NONHUMAN; PATCH CLAMP; POTASSIUM CURRENT; PRIORITY JOURNAL; PROTEIN FAMILY; RAT; VOLTAGE CLAMP;

ANGIOTENSIN II; ANIMALS; ANIMALS, NEWBORN; BENZOTHIAZOLES; BRAIN STEM; CELLS, CULTURED; CYCLOHEXANONES; DELAYED RECTIFIER POTASSIUM CHANNELS; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPOTHALAMUS; ION CHANNEL GATING; MEMBRANE POTENTIALS; NEURONS; PATCH-CLAMP TECHNIQUES; PROTEIN DISULFIDE REDUCTASE (GLUTATHIONE); RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; THIOREDOXIN; TIME FACTORS; UP-REGULATION;

RATTUS;

EID: 34547113323     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00615.2006     Document Type: Article

References (37)

1. Annunziato L, Pannaccione A, Cataldi M, Secondo A, Castaldo P, DiRenzo G, Taglialatela M. Modulation of ion channels by reactive oxygen and nitrogen species: a pathophysiological role in brain aging? Neurobiol Aging 23: 819-834, 2002.
2. Arner ESJ, Holmgren A. Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem 267: 6102-6109, 2000.
3. Bradshaw TD, Matthews CS, Cookson J, Chew EH, Shah M, Bailey K, Monks A, Harris E, Westwell AD, Wells G, Laughton CA, Stevens MF. Elucidation of thioredoxin as a molecular target for antitumor quinols. Cancer Res 65: 3911-3919, 2005.
4. Busche S, Gallinat S, Fleegal MA, Raizada MK, Sumners C. Novel role of macrophage migration inhibitory factor in angiotensin II regulation of neuromodulation in rat brain. Endocrinology 142: 4623-4630, 2001.
5. Ferguson AV, Washburn DL, Latchford KJ. Hormonal and neurotransmitter roles for angiotensin in the regulation of central autonomic function. Exp Biol Med (Maywood) 226: 85-96, 2001.
6. Fleegal MA, Sumners C. Angiotensin II induction of AP-1 in neurons requires stimulation of PI3-K and JNK. Biochem Biophys Res Commun 310: 470-477, 2003.
7. Jin MH, Lee YH, Kim JM, Sun HN, Moon EY, Shong MH, Kim SU, Lee TH, Yu DY, Lee DS. Characterization of neural cell types expressing peroxiredoxins in mouse brain. Neurosci Lett 381: 252-257, 2005.
8. Kaghad M, Dessarps F, Jacquemin-Sablon H, Caput D, Fradelizi D, Wollman EE. Genomic cloning of human thioredoxin-encoding gene: mapping of the transcription start point and analysis of the promoter. Gene 140: 273-278, 1994.
9. Kondo N, Ishii Y, Son A, Sakakura-Nishiyama J, Kwon YW, Tanito M, Nishinaka Y, Matsuo Y, Nakayama T, Taniguchi M, Yodoi J. Cysteine-dependent immune regulation by TRX and MIF/GIF family proteins. Immunol Lett 92: 143-147, 2004.
10. Kourie JI. Interaction of reactive oxygen species with ion transport mechanisms. Am J Physiol Cell Physiol 275: C1-C24, 1998.
11. Krishna CM, Liebmann JE, Kaufman D, DeGraff W, Hahn SM, McMurry T, Mitchell JB, Russo A. The catecholic metal sequestering agent 1,2-dihydroxybenzene-3,5-disulfonate confers protection against oxidative cell damage. Arch Biochem Biophys 294: 98-106, 1992.
12. Kunkel MW, Kirkpatrick DL, Johnson JI, Powis G. Cell line-directed screening assay for inhibitors of thioredoxin reductase signaling as potential anti-cancer drugs. Anticancer Drug Des 12: 659-670, 1997.
13. Li H, Gao Y, Freire CD, Raizada MK, Toney GM, Sumners C. Macrophage migration inhibitory factor in the PVN attenuates the central pressor and dipsogenic actions of angiotensin II. FASEB J 20: 1748-1750, 2006.
14. Lippoldt A, Padilla CA, Gerst H, Andbjer B, Richter E, Holmgren A, Fuxe K. Localization of thioredoxin in the rat brain and functional implications. J Neurosci 15: 6747-6756, 1995.
15. Liu W, Nakamura H, Shioji K, Tanito M, Oka S, Ahsan MK, Son A, Ishii Y, Kishimoto C, Yodoi J. Thioredoxin-1 ameliorates myosininduced autoimmune myocarditis by suppressing chemokine expressions and leukocyte chemotaxis in mice. Circulation 110: 1276-1283, 2004.
16. Masutani H, Hirota K, Sasada T, Ueda-Taniguchi Y, Taniguchi Y, Sono H, Yodoi J. Transactivation of an inducible anti-oxidative stress protein, human thioredoxin by HTLV-I Tax. Immunol Lett 54: 67-71, 1996.
17. + current. J Neurophysiol 95: 1042-1048, 2006.
18. McKinley MJ, Albiston AL, Allen AM, Mathai ML, May CN, McAllen RM, Oldfield BJ, Mendelsohn FA, Chai SY. The brain renin-angiotensin system: location and physiological roles. Int J Biochem Cell Biol 35: 901-918, 2003.
19. Mukherjee A, Westwell AD, Bradshaw TD, Stevens MF, Carmichael J, Martin SG. Cytotoxic and antiangiogenic activity of AW464 (NSC 706704), a novel thioredoxin inhibitor: an in vitro study. Br J Cancer 92: 350-358, 2005.
20. Pallis M, Bradshaw TD, Westwell AD, Grundy M, Stevens MF, Russell N. Induction of apoptosis without redox catastrophe by thioredoxin- inhibitory compounds. Biochem Pharmacol 66: 1695-1705, 2003.
21. Patenaude A, Murthy MRV, Mirault ME. Emerging roles of thioredoxin cycle enzymes in the central nervous system. Cell Mol Life Sci 62: 1063-1080, 2005.
22. Powis G, Montfort WR. Properties and biological activities of thioredoxins. Annu Rev Pharmacol Toxicol 41: 261-295, 2001.
23. Rodriguez-Martin E, Casarejos MJ, Canals S, de Bernardo S, Mena MA. Thiolic antioxidants protect from nitric oxide-induced toxicity in fetal midbrain cultures. Neuropharmacology 43: 877-888, 2002.
24. Schafer FQ, Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 30: 1191-1212, 2001.
25. Sumners C, Tang W, Zelezna B, Raizada MK. Angiotensin II receptor subtypes are coupled with distinct signal-transduction mechanisms in neurons and astrocytes from rat brain. Proc Natl Acad Sci USA 88: 7567-7571, 1991.
26. 2+ currents: intracellular mechanisms. Am J Physiol Cell Physiol 271: C154-C163, 1996.
27. 1 receptor signalling pathways in neurons. Clin Exp Pharmacol Physiol 29: 483-490, 2002.
28. Sun C, Li H, Leng L, Raizada MK, Bucala R, Sumners C. Macrophage migration inhibitory factor: an intracellular inhibitor of angiotensin IIinduced increases in neuronal activity. J Neurosci 24: 9944-9952, 2004.
29. Sun C, Sellers KW, Sumners C, Raizada MK. NAD(P)H oxidase inhibition attenuates neuronal chronotropic actions of angiotensin II. Circ Res 96: 659-666, 2005.
30. Taniguchi Y, Taniguchi-Ueda Y, Mori K, Yodoi J. A novel promoter sequence is involved in the oxidative stress-induced expression of the adult T-cell leukemia-derived factor (ADF)/human thioredoxin (Trx) gene. Nucleic Acids Res 24: 2746-2752, 1996.
31. Tanito M, Nakamura H, Kwon YW, Teratani A, Masutani H, Shioji K, Kishimoto C, Ohira A, Horie R, Yodoi J. Enhanced oxidative stress and impaired thioredoxin expression in spontaneously hypertensive rats. Antioxid Redox Signal 6: 89-97, 2004.
32. Thiele M, Bernhagen J. Link between macrophage migration inhibitory factor and cellular redox regulation. Antioxid Redox Signal 7: 1234-1248, 2005.
33. Wang D, Gelband CH, Sumners C, Posner P. Mechanisms underlying the chronotropic effect of angiotensin II on cultured neurons from rat hypothalamus and brain stem. J Neurophysiol 78: 1013-1020, 1997.
34. + current in neurons cultured from neuronal rat hypothalamus and brain stem: modulation by angiotensin II. J Neurophysiol 78: 1021-1029, 1997.
35. Wells G, Berry JM, Bradshaw TD, Burger AM, Seaton A, Wang B, Westwell AD, Stevens MF. 4-Substituted 4-hydroxycyclohexa-2,5-dien-1-ones with selective activities against colon and renal cancer cell lines. J Med Chem 46: 532-541, 2003.
36. Yamada J, Yoshimura S, Yamakawa H, Sawada M, Nakagawa M, Hara S, Kaku Y, Iwama T, Naganawa T, Banno Y, Nakashima S, Sakai N. Cell permeable ROS scavengers, Tiron and Tempol, rescue PC12 cell death caused by pyrogallol or hypoxia/reoxygenation. Neurosci Res 45: 1-8, 2003.
37. + current: role of 12-lipoxygenase metabolites of arachidonic acid. J Neurophysiol 84: 2494-2501, 2000.